PhRMA’s Post

Name: PhRMA on LinkedIn: The U.S. biopharmaceutical industry leads the world in developing…
Uploaded: 2024-07-16T16:26:27.352Z
Channel: PhRMA
Description: The U.S. biopharmaceutical industry leads the world in developing innovative vaccine technology. Each vial at the pharmacy and doctor’s office represents years of R&D by biopharmaceutical researchers. ⬇️ Download our new report to learn how our leadership in vaccine research ensures advancements can continue. https://lnkd.in/e9WRzBJw

PhRMA

57,818 followers

2mo

The U.S. biopharmaceutical industry leads the world in developing innovative vaccine technology. Each vial at the pharmacy and doctor’s office represents years of R&D by biopharmaceutical researchers. ⬇️ Download our new report to learn how our leadership in vaccine research ensures advancements can continue. https://lnkd.in/e9WRzBJw

1 Comment

Transcript

Hi, I'm Andrew Paolini. Let's talk about one area that health experts often note is one of the greatest public health interventions of all time, along with clean water. I'm talking about vaccines. Vaccines are one of the most impactful tools we have for preventing and mitigating diseases and supporting healthy aging. So here's what you need to know. Over the last 30 years in the US, childhood vaccines have prevented more than 1,000,000 deaths. Vaccines are available. To prevent 18 dangerous or deadly diseases and are estimated to have saved millions of lives in the United States alone. And thanks to vaccines, we've been able to greatly reduce the severity and toll of some diseases across people's lifespan. The backdrop US biopharmaceutical leadership and vaccine are indeed plays a vital role in protecting Americans and people around the world from health threats. See more in our new report on vaccines and development.

Darren Nelson 🚀 (We're hiring)

Helping Science & Technology companies find top talent through personalized recruitment solutions.

2mo

Impressive dedication, PhRMA! 💉 The commitment and innovation behind each vaccine vial highlight the industry's pivotal role in advancing healthcare worldwide. Looking forward to exploring your latest report to learn more about these groundbreaking achievements!

To view or add a comment, sign in

More Relevant Posts

Axel Ouvrard

Go-to-Market Strategy Lead, TFF & Viral clearance Portfolio chez Merck Group
9mo
Report this post
We conducted a global market survey on fully closed processing for biopharmaceutical manufacturing and gathered industry viewpoints in our new white paper: Perspectives On: The Adoption of Fully Closed Processing for Biopharmaceutical Manufacturing. Download this paper to learn about key findings from the research, as well as insights and perspectives from industry experts on the shift towards closed processing and its effects on the facility of the future.

Closed Processing for Biomanufacturing
Like Comment
To view or add a comment, sign in
Alexandre Crussaire

Senior Marketing Communication Manager - Downstream BioProcessing - Merck Life Science
9mo
Report this post
We conducted a global market survey on fully closed processing for biopharmaceutical manufacturing and gathered industry viewpoints in our new white paper: Perspectives On: The Adoption of Fully Closed Processing for Biopharmaceutical Manufacturing. Download this paper to learn about key findings from the research, as well as insights and perspectives from industry experts on the shift towards closed processing and its effects on the facility of the future.

Closed Processing for Biomanufacturing

2 Comments
Like Comment
To view or add a comment, sign in
Bruno Souza

Bioprocessing Marketing Excellence Manager
9mo
Report this post
We conducted a global market survey on fully closed processing for biopharmaceutical manufacturing and gathered industry viewpoints in our new white paper: Perspectives On: The Adoption of Fully Closed Processing for Biopharmaceutical Manufacturing. Download this paper to learn about key findings from the research, as well as insights and perspectives from industry experts on the shift towards closed processing and its effects on the facility of the future.

Closed Processing for Biomanufacturing

sigmaaldrich.com
Like Comment
To view or add a comment, sign in
Veronica Fineberg

Marketing Communications Manager for mAbs, Process Solutions
9mo
Report this post
We conducted a global market survey on fully closed processing for biopharmaceutical manufacturing and gathered industry viewpoints in our new white paper: Perspectives On: The Adoption of Fully Closed Processing for Biopharmaceutical Manufacturing. Download this paper to learn about key findings from the research, as well as insights and perspectives from industry experts on the shift towards closed processing and its effects on the facility of the future.

Closed Processing for Biomanufacturing

2 Comments
Like Comment
To view or add a comment, sign in
Yuliya Palkina

Manager at Worldwide Clinical Trials
4mo
Report this post
Are you interested in the future of biopharma funding decisions? Check out Peter Benton's interview with Biopharmaceutical Development & Manufacturing Network to discover his insights: https://bit.ly/4ejLdKY

Q&A with Peter Benton: Outlook for BioPharma Funding
Like Comment
To view or add a comment, sign in
Jelena Markovic

Senior Operations Associate, Clinical Assessment Technologies at Worldwide Clinical Trials
4mo
Report this post
Are you interested in the future of biopharma funding decisions? Check out Peter Benton's interview with Biopharmaceutical Development & Manufacturing Network to discover his insights: https://bit.ly/4ejLdKY

Q&A with Peter Benton: Outlook for BioPharma Funding
Like Comment
To view or add a comment, sign in
Richard Price

Clinical Systems | Clinical Trial Technology
3mo
Report this post
Are you interested in the future of biopharma funding decisions? Check out Peter Benton's interview with Biopharmaceutical Development & Manufacturing Network to discover his insights: https://bit.ly/4ejLdKY

Q&A with Peter Benton: Outlook for BioPharma Funding
Like Comment
To view or add a comment, sign in
Courtney Tait
3mo
Report this post
Are you interested in the future of biopharma funding decisions? Check out Peter Benton's interview with Biopharmaceutical Development & Manufacturing Network to discover his insights: https://bit.ly/4ejLdKY

Q&A with Peter Benton: Outlook for BioPharma Funding
Like Comment
To view or add a comment, sign in
Viktorija Mihajlovic

HR Manager @ Brick Pro Real Estate| Diversity Inclusion and Belonging
3mo
Report this post
Are you interested in the future of biopharma funding decisions? Check out Peter Benton's interview with Biopharmaceutical Development & Manufacturing Network to discover his insights: https://bit.ly/4ejLdKY

Q&A with Peter Benton: Outlook for BioPharma Funding
Like Comment
To view or add a comment, sign in
Gordana Mihailovic

Worldwide Clinical Trials Talent Systems Admin&Analyst
4mo
Report this post
Are you interested in the future of biopharma funding decisions? Check out Peter Benton's interview with Biopharmaceutical Development & Manufacturing Network to discover his insights: https://bit.ly/4ejLdKY

Q&A with Peter Benton: Outlook for BioPharma Funding
Like Comment
To view or add a comment, sign in

57,818 followers

View Profile Follow

PhRMA’s Post

Transcript

More Relevant Posts

Explore topics